| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/27/1991 | EP0413751A1 Neurologically active compounds |
| 02/27/1991 | EP0413694A1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker. |
| 02/26/1991 | CA1280690C Method for screening and treatment |
| 02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
| 02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
| 02/21/1991 | WO1991001756A1 Method for chemical promotion of the effects of low current transcranial electrostimulation |
| 02/21/1991 | WO1991001724A1 Renal-selective prodrugs for the treatment of hypertension |
| 02/21/1991 | WO1991001723A1 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 02/21/1991 | WO1991001624A2 Use of calcium antagonists for treating scars |
| 02/21/1991 | WO1991000281A3 Fused-ring aryl substituted imidazoles |
| 02/20/1991 | EP0413533A1 Microencapsulated taste-masked water-insoluble NSAID drug materials |
| 02/20/1991 | EP0413528A1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 02/20/1991 | CN1011659B Preparation of a composition based on a finely divided active principle of low water solubility |
| 02/19/1991 | CA1280414C Isoprenoidamine derivatives and antiulcer agents |
| 02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/13/1991 | EP0412702A2 Mixtures of fatty amines from polyoxyalkyleneamines |
| 02/12/1991 | CA2022410A1 Mixtures of fatty amines from polyoxyalkyleneamines |
| 02/09/1991 | WO1991001729A1 Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/05/1991 | US4990538 Administering for the treatment of cancer |
| 02/03/1991 | WO1991001749A1 Method of treatment with medical agents |
| 02/01/1991 | WO1991001725A1 A NOVEL USE OF β-RECEPTOR BLOCKING AGENTS FOR TREATMENT OF MENIERES' DISEASE |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0409957A1 Biological fluids purification systems |
| 01/30/1991 | EP0409940A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. |
| 01/29/1991 | US4988700 Antiserotonin agent, aryl or heteroaryl piperazine compounds |
| 01/24/1991 | WO1991000731A1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 01/24/1991 | DE3923848A1 De-masking of autologous immunocyte(s) - used in immuno-therapy of tumours |
| 01/23/1991 | EP0409690A1 Skinproducts with cosmetic and/or therapeutic effects |
| 01/23/1991 | EP0409406A2 Aryl-substituted amine derivatives useful in cancer therapy |
| 01/23/1991 | EP0408650A1 Method and composition for treating neurological disorders |
| 01/22/1991 | US4987237 Immunostimulant suitable for coupling to other materials |
| 01/17/1991 | DE3943519A1 Treatment of erectile dysfunction - with peptide aspartic-acid -leucine -glutamine -alanine |
| 01/16/1991 | EP0408496A2 Solid dosage form for pharmaceutical substances |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0407804A1 Water soluble pharmaceutical composition containing metallocen-complex |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/15/1991 | US4985459 Containing non-steroidal antiinflammatory drugs |
| 01/13/1991 | CA2020802A1 Solid dosage form for pharmaceutically active drugs |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000081A2 Anti-malarial composition and method of use |
| 01/08/1991 | US4983779 Coupling carbonyl compound with ester in organic solvent in presence of metallic reducing agent, titanium salt, amine base |
| 01/08/1991 | US4983621 Antiemetic mixture of cyclooxygenase inhibitor and 1,2,3,4-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h -carbazol-4-one |
| 01/08/1991 | US4983598 Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor |
| 01/08/1991 | US4983401 Sustained release pharmaceutical preparations having pH controlled membrane coatings |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | CA2035868A1 Hybrid molecules |
| 01/02/1991 | EP0405315A2 Use of a phagocyte-activating agent : LPS or IL-2 for the manufacture of a medicament for treating staphylococcus aureus infection in cows |
| 01/02/1991 | CA1278515C Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 01/01/1991 | US4981979 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 12/31/1990 | WO1991000281A2 Fused-ring aryl substituted imidazoles |
| 12/31/1990 | WO1991000277A1 Substituted imidazoles |
| 12/31/1990 | CA2060656A1 Substituted imidazoles |
| 12/27/1990 | WO1990015604A1 Treatment and control of ocular development |
| 12/27/1990 | EP0404334A1 Aerosol compositions for topical application |
| 12/27/1990 | EP0404205A1 Composition for noninvasive administration of sedatives and analgesics |
| 12/27/1990 | EP0214995B1 Immunotoxin and method of making |
| 12/27/1990 | CA1278299C Bicyclic catechol derivatives, a preparation process thereof and therapeutical compositions containing the same |
| 12/26/1990 | CA2017412A1 Method for preventing or treating depression employing an ace inhibitor |
| 12/25/1990 | US4980175 Liquid orally administrable compositions based on edible oils |
| 12/20/1990 | WO1990015599A1 Medicaments useful in cancer therapy and having antihistaminic properties |
| 12/20/1990 | CA2059127A1 Medicaments useful in cancer therapy and having antihistaminic properties |
| 12/19/1990 | EP0403251A2 Monokine activity interference |
| 12/19/1990 | EP0403048A2 Medicated compositions containing sucralfate and processes for their production |
| 12/19/1990 | EP0402422A1 Certain paf antagonist antihistamine combinations and methods |
| 12/18/1990 | US4978332 Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| 12/18/1990 | CA1277914C Use of dopamine agonists |
| 12/14/1990 | WO1990015534A1 Monokine activity interference |
| 12/14/1990 | CA2058952A1 Monokine activity interference |
| 12/14/1990 | CA2018945A1 Sucralfate and a medicament and methods for preparing same |
| 12/13/1990 | WO1990014843A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy |
| 12/12/1990 | EP0402088A2 Conjugate immunogen for aids |
| 12/12/1990 | EP0401705A2 Use of an HMG CoA reductase inhibitor and/or a squalene synthetase inhibitor for treating peripheral atherosclerotic disease |
| 12/12/1990 | EP0401505A2 Pharmaceutical composition containing a potassium channel-activator and an ace-inhibitor |
| 12/12/1990 | EP0401243A1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives. |
| 12/11/1990 | US4977170 Isoprenoidamine compounds which are useful antiulcer agents |
| 12/11/1990 | CA1277564C Dermal and transdermal patches having a discontinuous pattern adhesive layer |
| 12/06/1990 | DE3917852A1 Medikamente zur tumortherapie mit kontrolliertem und reguliertem immunsystem sowie verwendung der einzelsubstanzen zur kombinierten therapie Drugs for tumor therapy with controlled and regulated immune system as well as use of individual substances for combined therapy |
| 12/06/1990 | CA2018297A1 Conjugate immunogen for aids |
| 12/06/1990 | CA2017923A1 Heated oral antitussive compositions |
| 12/05/1990 | EP0400665A2 Use of a calcium channel blocker for preventing or treating anxiety |
| 12/05/1990 | EP0400584A2 Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof |
| 12/05/1990 | EP0400522A2 Process for the preparation of micronised biodegradable particles |
| 12/05/1990 | CA2016467A1 Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
| 12/04/1990 | US4975453 Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals |
| 12/04/1990 | US4975452 Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof |
| 12/04/1990 | US4975436 Treatment of anxiety |
| 12/04/1990 | US4975281 Agent forming protective complex in acid environment and alkaline material; preventing formation in and adherence to mouth |
| 12/04/1990 | CA1277232C Methods and compositions for the treatment of gastrointestinal disorders |
| 12/02/1990 | CA2016465A1 Method for preventing or treating anxiety employing a calcium channel blocker |
| 12/02/1990 | CA2016464A1 Geminally substituted thiaheterocyclic carboxylic acids and derivatives thereof |
| 11/29/1990 | WO1990014077A1 SUSTAINED RELEASE PHARMACEUTICAL PREPARATIONS HAVING pH CONTROLLED MEMBRANE COATINGS |
| 11/29/1990 | WO1990011758A3 Use of a potassic agonist in the treatment of glaucoma |
| 11/28/1990 | EP0399818A1 Diarylstyrylquinoline diacids |
| 11/28/1990 | EP0399791A1 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| 11/28/1990 | EP0399631A1 Use of gestodene for the production of pharmaceutical agents |
| 11/28/1990 | EP0399423A2 Method for transplantation of fertilized ova |
| 11/28/1990 | CN1047298A Application for gestodene in manufacture of pharmaceutical |
| 11/27/1990 | US4973589 Method of preventing the reinfestation of dogs and cats by fleas |